{"meshTags":["Aged","Brachytherapy","Gastrointestinal Diseases","Humans","Male","Middle Aged","Prognosis","Prostate-Specific Antigen","Prostatic Neoplasms","Radiation Injuries","Radiotherapy Dosage","Radiotherapy, Conformal","Radiotherapy, Intensity-Modulated","Urination Disorders"],"meshMinor":["Aged","Brachytherapy","Gastrointestinal Diseases","Humans","Male","Middle Aged","Prognosis","Prostate-Specific Antigen","Prostatic Neoplasms","Radiation Injuries","Radiotherapy Dosage","Radiotherapy, Conformal","Radiotherapy, Intensity-Modulated","Urination Disorders"],"genes":["HDR"],"publicationTypes":["Journal Article"],"abstract":"Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal.The treatment regimen of HDR brachytherapy and external beam radiotherapy is a safe and very effective treatment for patients with high risk localized prostate cancer with excellent biochemical control and low toxicity.","title":"Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer.","pubmedId":"22397528"}